| Literature DB >> 30453644 |
Yuki Miyake1,2, Eri Eguchi3, Hiroshi Ito4, Kazufumi Nakamura5, Tatsuo Ito6, Kenjiro Nagaoka7, Noriyoshi Ogino8, Keiki Ogino9.
Abstract
The purpose of this study was to investigate the relationship between occupational dysfunction and metabolic syndrome (MetS) and its component factors in community-dwelling Japanese adults (N = 1,514). Self-reported lifestyle behaviors, Classification and Assessment of Occupational Dysfunction (CAOD) scores, and metabolic traits were measured. CAOD levels were divided into tertiles (low, moderate, and high), and their associations with MetS and its components were evaluated through logistic regression analysis. The association of MetS with CAOD was demonstrated in the total number of individuals [OR = 1.92 (95% CI 1.17⁻3.17)] and in older individuals [OR = 1.90 (95% CI 1.04⁻3.46)]. The association of dyslipidemia and CAOD was evident for overweight individuals [OR = 2.08 (95% CI 1.17⁻3.68)]. A higher association of high blood pressure with CAOD was evidenced in younger individuals [OR = 2.02 (95% CI 1.05⁻3.89)] who belonged to the highest-CAOD-score group in comparison to those who registered the lowest-CAOD-score group. The evaluation of MetS and interventions related to its prevention may be more effective if the viewpoint of occupational dysfunction is taken into account.Entities:
Keywords: community-dwelling people; metabolic syndrome; occupational dysfunction
Mesh:
Year: 2018 PMID: 30453644 PMCID: PMC6266595 DOI: 10.3390/ijerph15112575
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Mean age, age- and sex-adjusted mean values, prevalence of clinical parameters, and lifestyles of subjects.
| Variables | All ( | ||||||
|---|---|---|---|---|---|---|---|
| CAOD Score |
| ||||||
| 16–19 | 20–30 | 31≥ | |||||
| CAOD median | 16 | 24 | 39 | - | |||
| Number | 489 | 516 | 509 | - | |||
| Male | 229 | 209 | 220 | - | |||
| Female | 260 | 307 | 289 | - | |||
| Age (years) | 72.0 | 71.3 | 68.5 | <0.0001 | |||
| BMI (kg/m2) | 23.0 | 22.7 | 22.4 | * |
| 0.002 | |
| SBP (mmHg) | 133.3 | 131.9 | 130.5 | * | 0.069 | 0.02 | |
| DBP (mmHg) | 72.8 | 71.4 | * | 70.0 | ** |
| <0.0001 |
| TG (mg/dL) | 114.8 | 114.1 | 111.1 | 0.67 | 0.40 | ||
| HDL-C (mg/dL) | 56.4 | 57.3 | 57.7 | 0.303 | 0.13 | ||
| LDL-C (mg/dL) | 126.6 | 122.2 | * | 121.4 | ** |
| 0.005 |
| HbA1c (%) | 5.7 | 5.7 | 5.7 | 0.411 | 0.81 | ||
| Metabolic syndrome, % | 12.5 | 9.7 | 14.2 | 0.175 | 0.67 | ||
| Current Smoker, % | 7.0 | 5.6 | 10.0 | 0.226 | 0.22 | ||
| Regular Alcohol intake, % | 20.7 | 20.5 | 21.0 | 0.643 | 0.67 | ||
| Exercise habits, % | 54.6 | 53.3 | ** | 44.8 | ** |
| 0.002 |
| Deficiency of sleep, % | 15.1 | 28.9 | ** | 38.9 | ** |
| <0.0001 |
| High school or higher education, % | 74.9 | 76.4 | 77.4 | 0.893 | 0.89 | ||
| Marital status (married), % | 75.7 | 76.6 | 75.4 | 0.807 | 0.97 | ||
CAOD: Classification and Assessment of Occupational Dysfunction; BMI: Body Mass Index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; Metabolic syndrome: BMI ≥ 25 and two or more of following factors: (1) HDL-C of <40 mg/dl and/or TG of ≥150 mg/dl and/or medication for dyslipidemia; (2) SBP ≥ 130 mmHg and/or DBP ≥ 85 mmHg and/or medication for hypertension; and (3) HbA1c ≥ 6.0; prevalence of clinical parameters and life styles of all subjects adjusted by age and sex. Significant differences (p < 0.05) by age and sex-adjusted ANCOVA and linear trend among the values of several clinical parameters in CAOD score categories. After ANCOVA, multiple comparisons (Bonferroni) were performed. ** p < 0.01, * p < 0.05 through multiple comparisons.
Multivariable-adjusted odds ratios and 95% confidence intervals for metabolic syndrome and each of its component factors according to CAOD score categories in all participants and stratified by overweight status and age categories.
| Total (n = 1514) | ||||||
|---|---|---|---|---|---|---|
| CAOD Score | ||||||
| 16–19 | 20–30 | ≥31 | ||||
| Number | 489 | 516 | 509 | |||
|
| ||||||
| Metabolic syndrome | ||||||
| No. | 61 | 50 | 72 | |||
| unadjusted OR (95% CI) | 1.00 | 0.75 (0.51–1.12) | 1.16 (0.80–1.67) | 0.24 | ||
| Multivariable OR (95% CI) | 1.00 | 0.79 (0.47–1.33) |
|
| ||
| High blood pressure | ||||||
| No. | 319 | 349 | 319 | |||
| unadjusted OR (95% CI) | 1.00 | 1.11 (0.86–1.45) | 0.90 (0.69–1.16) | 0.27 | ||
| Multivariable OR (95% CI) | 1.00 | 1.20 (0.91–1.58) | 1.12 (0.84–1.48) | 0.58 | ||
| Dyslipidemia | ||||||
| No. | 201 | 208 | 203 | |||
| unadjusted OR (95% CI) | 1.00 | 0.97 (0.75–1.25) | 0.95 (0.74–1.22) | 0.71 | ||
| Multivariable OR (95% CI) | 1.00 | 1.01 (0.78–1.30) | 0.99 (0.76–1.30) | 0.92 | ||
| Glucose intolerance | ||||||
| No. | 120 | 97 | 107 | |||
| unadjusted OR (95% CI) | 1.00 |
| 0.82 (0.61–1.10) | 0.32 | ||
| Multivariable OR (95% CI) | 1.00 | 0.75 (0.55–1.03) | 0.98 (0.71–1.34) | 0.88 | ||
|
| ||||||
| Metabolic syndrome | ||||||
| No. | – | – | – | |||
| unadjusted OR (95% CI) | – | – | – | |||
| Multivariable OR (95% CI) | – | – | – | |||
| High blood pressure | ||||||
| No. | 237 | 270 | 238 | |||
| unadjusted OR (95% CI) | 1.00 | 1.15 (0.86–1.54) | 0.86 (0.64–1.14) | 0.17 | ||
| Multivariable OR (95% CI) | 1.00 | 1.25 (0.92–1.70) | 1.08 (0.79–1.48) | 0.96 | ||
| Dyslipidemia | ||||||
| No. | 147 | 154 | 136 | |||
| unadjusted OR (95% CI) | 1.00 | 0.94 (0.71–1.26) | 0.80 (0.60–1.07) | 0.12 | ||
| Multivariable OR (95% CI) | 1.00 | 0.94 (0.70–1.27) | 0.79 (0.57–1.07) | 0.05 | ||
| Glucose intolerance | ||||||
| No. | 78 | 68 | 65 | |||
| unadjusted OR (95% CI) | 1.00 | 0.76 (0.53–1.10) | 0.74 (0.51–1.06) | 0.14 | ||
| Multivariable OR (95% CI) | 1.00 | 0.82 (0.57–1.19) | 0.90 (0.61–1.32) | 0.51 | ||
|
| ||||||
| Metabolic syndrome | ||||||
| No. | 61 | 50 | 72 | |||
| unadjusted OR (95% CI) | 1.00 | 0.74 (0.44–1.25) | 1.68 (0.98–2.87) | 0.03 | ||
| Multivariable OR (95% CI) | 1.00 | 0.85 (0.49–1.47) | 2.07 (1.15–3.71) | 0.01 | ||
| High blood pressure | ||||||
| No. | 82 | 79 | 81 | |||
| unadjusted OR (95% CI) | 1.00 | 1.03 (0.58–1.83) | 1.12 (0.63–2.02) | 0.69 | ||
| Multivariable OR (95% CI) | 1.00 | 1.04 (0.57–1.91) | 1.27 (0.68–2.38) | 0.53 | ||
| Dyslipidemia | ||||||
| No. | 54 | 54 | 67 | |||
| unadjusted OR (95% CI) | 1.00 | 1.09 (0.65–1.84) |
|
| ||
| Multivariable OR (95% CI) | 1.00 | 1.28 (0.74–2.21) |
|
| ||
| Glucose intolerance | ||||||
| No. | 42 | 29 | 42 | |||
| unadjusted OR (95% CI) | 1.00 | 0.62 (0.35–1.10) | 1.07 (0.63–1.84) | 0.56 | ||
| Multivariable OR (95% CI) | 1.00 | 0.61 (0.34–1.10) | 1.13 (0.64–1.99) | 0.47 | ||
|
| ||||||
| Metabolic syndrome | ||||||
| No. | 9 | 11 | 24 | |||
| unadjusted OR (95% CI) | 1.00 | 0.98 (0.38–2.53) | 1.40 (0.61–3.20) | 0.32 | ||
| Multivariable OR (95% CI) | 1.00 | 1.34 (0.40–4.44) | 2.34 (0.78–7.08) | 0.36 | ||
| High blood pressure | ||||||
| No. | 33 | 52 | 72 | |||
| unadjusted OR (95% CI) | 1.00 | 1.66 (0.89–3.13) | 1.18 (0.67–2.10) | 0.99 | ||
| Multivariable OR (95% CI) | 1.00 |
|
|
| ||
| Dyslipidemia | ||||||
| No. | 29 | 35 | 50 | |||
| unadjusted OR (95% CI) | 1.00 | 0.96 (0.51–1.81) | 0.79 (0.44–1.41) | 0.37 | ||
| Multivariable OR (95% CI) | 1.00 | 1.10 (0.55–2.18) | 0.76 (0.40–1.47) | 0.17 | ||
| Glucose intolerance | ||||||
| No. | 18 | 11 | 14 | |||
| unadjusted OR (95% CI) | 1.00 |
|
|
| ||
| Multivariable OR (95% CI) | 1.00 | 0.51 (0.21–1.25) |
|
| ||
|
| ||||||
| Metabolic syndrome | ||||||
| No. | 52 | 39 | 48 | |||
| unadjusted OR (95% CI) | 1.00 | 0.71 (0.46–1.10) | 1.06 (0.70–1.61) | 0.59 | ||
| Multivariable OR (95% CI) | 1.00 | 0.78 (0.43–1.42) |
| 0.68 | ||
| High blood pressure | ||||||
| No. | 286 | 297 | 247 | |||
| unadjusted OR (95% CI) | 1.00 | 1.05 (0.78–1.40) | 0.95 (0.70–1.28) | 0.68 | ||
| Multivariable OR (95% CI) | 1.00 | 1.08 (0.80–1.45) | 1.00 (0.73–1.37) | 0.68 | ||
| Dyslipidemia | ||||||
| No. | 172 | 173 | 153 | |||
| unadjusted OR (95% CI) | 1.00 | 0.97 (0.74–1.28) | 1.02 (0.77–1.36) | 0.84 | ||
| Multivariable OR (95% CI) | 1.00 | 1.00 (0.75–1.32) | 1.07 (0.79–1.45) | 0.97 | ||
| Glucose intolerance | ||||||
| No. | 102 | 86 | 93 | |||
| unadjusted OR (95% CI) | 1.00 | 0.78 (0.56–1.08) | 1.05 (0.76–1.45) | 0.57 | ||
| Multivariable OR (95% CI) | 1.00 | 0.81 (0.58–1.13) | 1.17 (0.83–1.65) | 0.46 | ||
Multivariable OR: adjusted for sex, age, BMI, smoking habits, regular alcohol intake, sleep, exercise habits, marital status, and education status; data are reported as odds ratio (95% confidence interval); high blood pressure refers to systolic blood pressure ≥ 130 mmHg, diastolic blood pressure ≥ 85 mmHg, and/or medication for hypertension; dyslipidemia denotes high-density lipoprotein cholesterol < 40 mg/dL, triglycerides ≥150 mg/dL, and/or medication for dyslipidemia; glucose intolerance is signified by HbA1c ≥ 6.0% (NGSP) and/or medication for glucose intolerance; CAOD: Classification and Assessment of Occupational Dysfunction; OR: odds ratio; CI: confidence interval; BMI: body mass index.
Multivariable-adjusted odds ratios and 95% confidence intervals for metabolic syndrome and each of its component factors according to CAOD score categories stratified by a combination of overweight status and age categories.
| Total ( | ||||||
|---|---|---|---|---|---|---|
| CAOD Score | ||||||
| 16–19 | 20–30 | ≥31 | ||||
| Number | 489 | 516 | 509 | |||
|
| ||||||
| Metabolic syndrome | ||||||
| No. | – | – | – | |||
| unadjusted OR (95% CI) | – | – | – | |||
| Multivariable OR (95% CI) | – | – | – | |||
| High blood pressure | ||||||
| No. | 219 | 238 | 196 | |||
| unadjusted OR (95% CI) | 1.00 | 1.09 (0.79–1.50) | 0.94 (0.67–1.31) | 0.62 | ||
| Multivariable OR (95% CI) | 1.00 | 1.13 (0.81–1.58) | 1.00 (0.71–1.42) | 0.74 | ||
| Dyslipidemia | ||||||
| No. | 126 | 133 | 108 | |||
| unadjusted OR (95% CI) | 1.00 | 1.00 (0.73–1.36) | 0.90 (0.65–1.25) | 0.51 | ||
| Multivariable OR (95% CI) | 1.00 | 0.98 (0.71–1.35) | 0.90 (0.64–1.27) | 0.37 | ||
| Glucose intolerance | ||||||
| No. | 68 | 63 | 63 | |||
| unadjusted OR (95% CI) | 1.00 | 0.85 (0.58–1.24) | 1.02 (0.69–1.50) | 0.81 | ||
| Multivariable OR (95% CI) | 1.00 | 0.89 (0.60–1.32) | 1.12 (0.75–1.68) | 0.68 | ||
|
| ||||||
| Metabolic syndrome | ||||||
| No. | 52 | 39 | 48 | |||
| unadjusted OR (95% CI) | 1.00 | 0.68 (0.37–1.24) | 1.80 (0.92–3.51) | 0.06 | ||
| Multivariable OR (95% CI) | 1.00 | 0.72 (0.38–1.35) | 2.01 (0.99–4.06) | 0.04 | ||
| High blood pressure | ||||||
| No. | 67 | 59 | 51 | |||
| unadjusted OR (95% CI) | 1.00 | 0.92 (0.47–1.80) | 1.08 (0.52–2.21) | 0.82 | ||
| Multivariable OR (95% CI) | 1.00 | 0.84 (0.41–1.71) | 1.07 (0.50–2.29) | 0.93 | ||
| Dyslipidemia | ||||||
| No. | 46 | 40 | 45 | |||
| unadjusted OR (95% CI) | 1.00 | 0.93 (0.51–1.69) |
|
| ||
| Multivariable OR (95% CI) | 1.00 | 1.04 (0.56–1.95) |
|
| ||
| Glucose intolerance | ||||||
| No. | 34 | 23 | 30 | |||
| unadjusted OR (95% CI) | 1.00 | 0.65 (0.34–1.24) | 1.32 (0.70–2.51) | 0.30 | ||
| Multivariable OR (95% CI) | 1.00 | 0.62 (0.32–1.21) | 1.26 (0.64–2.47) | 0.39 | ||
|
| ||||||
| Metabolic syndrome | ||||||
| No. | – | – | – | |||
| unadjusted OR (95% CI) | – | – | – | |||
| Multivariable OR (95% CI) | – | – | – | |||
| High blood pressure | ||||||
| No. | 18 | 32 | 42 | |||
| unadjusted OR (95% CI) | 1.00 | 1.84 (0.85–4.00) | 1.17 (0.57–2.37) | 0.84 | ||
| Multivariable OR (95% CI) | 1.00 |
| 1.87 (0.83–4.22) | 0.50 | ||
| Dyslipidemia | ||||||
| No. | 21 | 21 | 28 | |||
| unadjusted OR (95% CI) | 1.00 | 0.67 (0.31–1.46) | 0.48 (0.23–0.99) |
| ||
| Multivariable OR (95% CI) | 1.00 | 0.67 (0.28–1.58) | 0.35 (0.15–0.82) |
| ||
| Glucose intolerance | ||||||
| No. | – | – | – | |||
| unadjusted OR (95% CI) | – | – | – | |||
| Multivariable OR (95% CI) | – | – | – | |||
|
| ||||||
| Metabolic syndrome | ||||||
| No. | 9 | 11 | 24 | |||
| unadjusted OR (95% CI) | 1.00 | 1.08 (0.35–3.31) | 2.22 (0.80–6.21) | 0.08 | ||
| Multivariable OR (95% CI) | 1.00 | 2.25 (0.57–8.89) | 3.84 (0.91–16.17) | 0.07 | ||
| High blood pressure | ||||||
| No. | 15 | 20 | 30 | |||
| unadjusted OR (95% CI) | 1.00 | 1.50 (0.47–4.81) | 1.50 (0.52–4.35) | 0.54 | ||
| Multivariable OR (95% CI) | 1.00 | 1.80 (0.48–6.74) | 2.94 (0.75–11.52) a | 0.15 | ||
| Dyslipidemia | ||||||
| No. | 8 | 14 | 22 | |||
| unadjusted OR (95% CI) | 1.00 | 2.00 (0.65–6.17) | 2.20 (0.78–6.24) | 0.20 | ||
| Multivariable OR (95% CI) | 1.00 |
| 3.11 (0.84–11.48) | 0.17 | ||
| Glucose intolerance | ||||||
| No. | 8 | 6 | 12 | |||
| unadjusted OR (95% CI) | 1.00 | 0.55 (0.16–1.88) | 0.80 (0.27–2.36) | 0.90 | ||
| Multivariable OR (95% CI) | 1.00 | 0.70 (0.18–2.74) | 0.61 (0.17–2.22) | 0.49 | ||
Multivariable OR: adjusted for sex, age, BMI, smoking habits, regular alcohol intake, sleep, exercise habits, marital status, and education status; a; adjusted for age, BMI, smoking habits, regular alcohol intake, sleep, exercise habits, marital status; data are reported as odds ratio (95% confidence interval); high blood pressure refers to systolic blood pressure ≥ 130 mmHg, diastolic blood pressure ≥ 85 mmHg and/or medication for hypertension; dyslipidemia denotes high-density lipoprotein cholesterol < 40 mg/dL, triglycerides ≥ 150 mg/dL and/or medication for dyslipidemia; glucose intolerance is taken as HbA1c ≥ 6.0% (NGSP) and/or medication for glucose intolerance. CAOD: Classification and Assessment of Occupational Dysfunction; OR: odds ratio; CI: confidence interval; BMI: body mass index.